Alcyomics®

If you are interested in finding out more about our Skimune® platform assays, please visit our website, alcyomics.com

Our assay is capable of a wide array of readouts. Saves time and money in product development. Can distinguish the type of hypersensitivity reaction. Readouts include cytokine release, immunohistochemistry and histopathology. Contact us for more info info@alcyomics.com

@NC3Rs @BBSRC Sounds good. Alcyomic will be checking it out!

We have partnered with @BBSRC to launch an ICURe Explore funding call to support the commercialisation of 3Rs tools and technologies. Learn more about the programme and register for the launch webinar on Wednesday 17 July: nc3rs.org.uk/news/announcin…

#SOTTV presents “Alcyomics Ltd.” Gain insight on the work being done at @Alcyomics and how its approach to using a human-based system may help predict adverse immune reactions to compounds in this paid film by @WebsEdge_Med. bit.ly/3tjdVWg

Hear from Professor Anne Dickinson, Founder and CEO of @Alcyomics, who explains how their products can help support the safety profile in Cell and Gene Therapy products. Watch ➡️ youtube.com/watch?v=BGLz3g…

@naattc @AnneBlackPharm @neilwwatson66 @cvniekerk1 @CGTCatapult @givebloodscot @LeedsHospitals Great to be part if NAATC!

🧬Here are many of the Northern Alliance team who met this week to celebrate the success of the project so far and plan for the future...🧬

Our recent paper in JITC describing a really fascinating case of #SJS secondary to contrast media following #ICI the therapy. Biological samples from this patient are already helping us to understand the mechanism of pathogenesis in skin blistering ADRs. twitter.com/immunopharm/st…

On @ScienceWeekUK we want say how proud we are of all of the businesses and scientists that call @BiosphereNCL home - Innovating for the future and supporting people to live well. #BSW21

@nvisionabdn Loved the realistic comparison of career progression within academia versus industry. Thanks Claire Pearce @EvOx_Ltd and Shaheda Ahmed @Alcyomics.

For International Women's Day & British Science Week 2020 we celebrated the careers of several influential women working in STEM, including @ChiOnwurah MP, Professor Ruth Plummer (@UniofNewcastle) & Dr Shaheda Ahmed (@Alcyomics) thebiospherenewcastle.co.uk/2020/03/11/new… #WomenInSTEM

Discovered this event - Festival of Biologics USA on #FOBUSA2021 We will be there! terrapinn.com/FestivalofBiol… #FOBUSA2021 via @totalbiopharma

Theres still time to apply for this exciting PhD studentship working in my group in collaboration with @ImmunoPharm and @Alcyomics developing models of severe skin adverse drug reactions. happy to chat with anyone interested (d.carr@liverpool.ac.uk). findaphd.com/search/Project…

Planning on applying for a PhD to start in 2021? @The_MRC funded project with DiMeN: Use of 3D skin models to elucidate the molecular pathogenesis of epidermal detachment in severe drug-induced skin reactions Liverpool: Dr Dan Carr & iCASE @Alcyomics findaphd.com/search/Project…

Exciting @DiMeN_DTP funded PhD opportunity in my group working with ⁦@ImmunoPharm⁩ at ⁦⁦@LivUniISMIB ⁦@LivUni⁩ and ⁦@Alcyomics⁩ developing in vitro models of severe skin adverse drug reactions. findaphd.com/search/Project…

We’re delighted that our partner @Alcyomics has been successful in its bid for a Fast Start grant of £50,000 from @innovateuk to undertake critical scientific support to aid in the development of a vaccine for #COVID19. Read more ⬇️ theattcnetwork.co.uk/news/alcyomics…

Check out this @REPROCELLglobal webinar. Alcyomics will be presenting our #immune based assays for #covid19 drug discovery.

Regulatory #safety guidelines for novel product classes can be insufficient. Here authors present a case for developing a new regulatory approach for the safety assessment of a specific category of biological medicinal products. medicalxpress.com/news/2020-06-r…

IIVS' outreach program for non-animal test methods supported by Chinese #cosmetic company. Good news showing this important market moving towards #nonaninal based tests. eurekalert.org/e/J1c4 via @the_iivs @EurekAlert

Join us for our webinar today - discussing strategies to assess #immunogencity and #immunotoxicity to #smallmolecules and #biologics using human-based platforms. Tuesday 23rd July. Register here: 12pm (BST) - bit.ly/37E5Nnu 5pm (BST) - bit.ly/3foIl03

Join us for our next webinar 'Providing Safety Testing Solutions for the Pharmaceutical Industry' on Tuesday 23rd June. #smallmolecule, #biologics #drugdiscovery #Skimune Register here: 12pm (BST) - bit.ly/37E5Nnu 5pm (BST) - bit.ly/3foIl03